CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
mLab App Plusbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06059443
NCT06059443N/ACompleted
CompareCT.gov

mLab App Plus: A Randomized Controlled Trial of an mHealth Intervention for Increasing Access to HIV and Syphilis Testing and Care Among Young Men

Columbia University·interventional·Posted Sep 28, 2023·Updated Mar 5, 2025

In Brief

A clinical study evaluating mLab App Plus for HIV Infections and 2 related conditions. Completed, enrolled 40 participants across 2 sites.

Detailed Summary

Men who have sex with men (MSM), especially young men who have sex with men (YMSM), and transgender women (TGW) have some of the highest rates of HIV and syphilis diagnoses in the United States. The goal of this study is to pilot the mobile Lab (mLab) App Plus to assess YMSM's and YTGW's abilities to perform and interpret self-tests for HIV and syphilis and consequently increase the number of YMSM and young transgender woman (YTGW) who initiate self-testing for HIV and syphilis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections, Sexually Transmitted Diseases, Viral, Syphilis
CountriesUnited States
CollaboratorsNational Institute of Nursing Research (NINR), National Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
202420252026
First PostedSep 28, 2023
Enrollment StartOct 17, 2023
Primary CompletionJun 21, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 2.8 years ago

Interventions

mLab App Plusbehavioral

Participants will use the mLab Plus app to test for Syphilis and HIV using the DPP HIV/Syphilis Test